---
title: "TA: Q2 2026 delivered strong cash flow and improved net earnings, with strategic growth and disciplined risk management"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294503524.md"
description: "Q2 2026 saw strong operational performance and improved net earnings, despite lower Adjusted EBITDA and FCF year-over-year. Strategic acquisitions, executive changes, and robust hedging supported results, while regulatory and market shifts in Alberta and the U.S. remain key risks.Original document: TransAlta Corporation [TA] SEC 6-K Current Report — Jul. 31 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-31T11:06:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294503524.md)
  - [en](https://longbridge.com/en/news/294503524.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294503524.md)
---

# TA: Q2 2026 delivered strong cash flow and improved net earnings, with strategic growth and disciplined risk management

Q2 2026 saw strong operational performance and improved net earnings, despite lower Adjusted EBITDA and FCF year-over-year. Strategic acquisitions, executive changes, and robust hedging supported results, while regulatory and market shifts in Alberta and the U.S. remain key risks.

Original document: TransAlta Corporation \[TA\] SEC 6-K Current Report — Jul. 31 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [TAC.US](https://longbridge.com/en/quote/TAC.US.md)

## Related News & Research

- [MLCI: Q2 2026 segment income surged 99% YoY, driven by insurance growth and strategic M&A](https://longbridge.com/en/news/295698837.md)
- [KMDA: Record-high revenue and profit growth in H1 and Q2 2026, with 2026 guidance reaffirmed](https://longbridge.com/en/news/295655423.md)
- [INR: Q2 2026 delivered record production, margin, and capital efficiency, with robust 2026 growth outlook](https://longbridge.com/en/news/295449560.md)
- [FOCL: Q2 2026 revenue up 39% to $13.2M; gross margin 55.6%; net loss $14.4M; 2026 guidance reiterated](https://longbridge.com/en/news/295839337.md)
- [AQST: Q2 2026 revenue up 38% to $13.8M; Anaphylm NDA resubmission on track for Q3 2026](https://longbridge.com/en/news/295573837.md)